Find More Contacts for Kerecis
Protected Content
CFO, Financial Officer
Executive Finance
1 email found 1 phone number found
View contacts for Kerecis to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email info@kerecis.com
  • Phone Number +1-703-287-8752

Kerecis develops patented fish-skin products to heal the human body. Because no disease-transfer risk exists between cold-water fish and humans, the Kerecis fish skin is only gently processed and retains its similarity to human skin, making it an ideal substitute for human skin. More than 50 studies have been done on Kerecis technology. Those

studies include two double-blind, comparative, randomized control trials, where fish skin treatment was more efficacious than mammalian-based treatments.

Kerecis is also developing products for areas such as oral surgery, plastic surgery, and neurological applications. The company's products utilize multiple patented fish-skin and fatty-acid technologies to protect and regenerate tissue.

Lists Featuring This Company

University of Iceland Alumni Founded Companies
87 Number of Organizations • $1.3B Total Funding Amount • 156 Number of Investors
Europe, Middle East, and Africa (EMEA) Medical Device Companies (Top 10K)
9,930 Number of Organizations • $37.4B Total Funding Amount • 6,494 Number of Investors
Investment Bank Funded Companies (Top 10K)
9,965 Number of Organizations • $3.1T Total Funding Amount • 100,613 Number of Investors
Private Europe Companies (Top 10K)
9,843 Number of Organizations • $725B Total Funding Amount • 60,818 Number of Investors
Kerecis was acquired by Coloplast for $1.3B on Jul 7, 2023.

Frequently Asked Questions

Where is Kerecis's headquarters? Kerecis is located in Ísafjörður, Vestur-Isafjardarsysla, Iceland.Who invested in Kerecis? Kerecis has 10 investors including Brú Pension Fund and Emerson Collective.How much funding has Kerecis raised to date? Kerecis has raised .When was the last funding round for Kerecis? Kerecis closed its last funding round on Jul 21, 2022 from a Series D round.Who are Kerecis's competitors? Alternatives and possible competitors to Kerecis may include QuantaQuVa Pharma, and Sinocelltech.